13th Annual Clinical Psychopharmacology Institute Report

13th Annual Clinical Psychopharmacology Institute
Planned for Nurses by Nurses

From Discovery to Recovery: Transforming Psychopharmacologic Nursing Practice

Hyatt Regency Baltimore on the Inner Harbor
300 Light Street
Baltimore, Maryland 21202
June 12-14, 2015

Overview

Thursday: 5:00 – 7:00 pm pre-conference
Friday 8:00 – 5:00pm & Saturday: 8:00 am – 5:15 pm
Sunday: 8:00 am – 3:30 pm

Registered attendees: 486 (as of June 1, 2015)
Earn up to 22 Continuing Nursing Education contact hours
Topics presented address psychopharmacology across the lifespan

Competency Based Training for Assessment and Prevention of Suicide

  • Prior to CPI - Thursday, June 11
  • 57 Registrants (as of June 2, 2015)


Learning Outcomes

  1. Relate new discoveries in psychopharmacology and neuroscience to the nursing practice of persons with complex psychiatric disorders across the lifespan.
  2. Review evidence-based pharmacologic approaches for persons with comorbid substance use and psychiatric illness across the lifespan.
  3. Discuss integrative treatments relevant to the continuum of wellness and recovery in addressing clinical psychopharmacological issues.

 

Program

Keynote Speakers:

Eric D. Green, MD, PhD
Director, National Human Genome Research Institute, National Institutes of Health; Human Genomes, Precision Medicine, and Advancing Human Health

Francis J. McMahon, MD
Chief, Human Genetics Branch and Genetic Basis of Mood and Anxiety Disorders Section, National Institute of Mental Health Intramural Research Program, National Institutes of Health; Genetics of Treatment Resistant Depression and Genetic Guidelines for Clinical Psychiatry

Faculty/Topics

Pre-conference session: Barbara Limandri, PhD, PMHNP, BC – Professor, Linfield College School of Nursing; Treating Persons with Borderline Personality Disorder from a Nursing Perspective

Carolyn Beebe Smith, PhD – Chief, Section on Neuroadaptation & Protein Metabolism, Intramural Research Program, National Institute of Mental Health, National Institutes of Health; Sleep-dependent Memory Consolidation: Understanding Core Processes

Pamela Z. Cacchione, PhD, CRNP, BC – Associate Professor of Geropsychic Nursing, University of Pennsylvania; Prescribing in Older Adults: From Anxiety to Dementia

Jess A. Calohan, DNP, MN, PMHNP-BC – Daniel K. Inouye Graduate School of Nursing, Uniformed Services University of the Health Sciences; Evidence-Based Prescribing Practices for Treating PTSD in Military Combat Veterans

Jessica M. Gill, PhD, RN – Lasker Clinical Research Scholar, Tissue Injury Branch, Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health; Neurobiological Mechanisms Related to Psychiatric Disorders After Traumatic Brain Injury

Mary A. Gutierrez, PharmD, BCPP – Professor of Pharmacy Practice (Psychiatry), Chapman University School of Pharmacy; Drug-drug Interactions, Pharmaceuticals, OTC, Herbal & Food Products

Gerald Overman, PharmD, BCPP – Clinical Pharmacy Specialist - Mental Health, Pharmacy Department, Clinical Center, National Institute of Mental Health, National Institutes of Health; Antipsychotic Treatment and Tolerability: Focus on Metabolic Syndrome

Daniel S. Pine, MD – Chief, Section on Development and Affective Neuroscience, National Institute of Mental Health Intramural Research Program, National Institutes of Health; Pediatric Mood and Anxiety Research: Uncovering Mechanisms and Pharmacologic Targets

Christena Raines, RN, MSN – Associate Director, Obstetrical Liaison and Community Outreach, UNC Perinatal Psychiatry Program; Perinatal Mood Disorders: Navigating Psychopharmacologic Options

Christian J. Teter, PharmD, BCPP – Associate Professor of Psychopharmacology, College of Pharmacy, University of New England; Buprenorphine 101 for Assessing and Managing Opioid Use Disorders

Julie Worley, PhD, FNP-BC, PMHNP-BC – Assistant Professor, Community Systems and Mental Health Nursing, Rush University College of Nursing; Doctor Shopping: What You Need to Know to Understand, Identify and Manage It

Additional Sessions

Symposium Luncheons

  • Friday - Evidence-based Treatment Approaches in Bipolar Depression: A Patient Spotlight (Sunovion)
  • Saturday - From the Molecule to the Mind: The Science of LAIs in Schizophrenia (Janssen)

Product Theater Dinner – Friday (Sunovion)

 



14th Annual Clinical Psychopharmacology Institute

Hyatt Regency Baltimore on the Inner Harbor

June 9-12, 2016

Keynote Speaker: John Kane

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.